ArticleFuture science OA2015

Combining infliximab, anti-MAP and hyperbaric oxygen therapy for resistant fistulizing Crohn's disease.

Gaurav Agrawal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.